| Colorectal Cancer Screening Intervention Trial (NCT00265720) | Morehouse School of Medicine | 2003-03-01 |
| Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer (NCT00061815) | Eli Lilly and Company | 2003-03-01 |
| Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer (NCT00123851) | Dana-Farber Cancer Institute | 2003-03-01 |
| Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors (NCT00054977) | Galectin Therapeutics Inc. | 2003-02-01 |
| S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed (NCT00049335) | SWOG Cancer Research Network | 2003-02-01 |
| Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer (NCT00094809) | Amgen | 2003-02-01 |
| Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy (NCT00625066) | Vanderbilt University | 2003-01-01 |
| Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer (NCT00059930) | Memorial Sloan Kettering Cancer Center | 2003-01-01 |
| Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer (NCT00052507) | University Health Network, Toronto | 2003-01-01 |
| Molecular Characteristics of Early-onset Compared With Late-onset Colorectal Cancer (NCT06238193) | The First Affiliated Hospital with Nanjing Medical University | 2003-01-01 |
| Early Lymph Node Metastasis in T1/2 Stage Colorectal Cancer: Molecular and Clinical Insights (NCT06130644) | The First Affiliated Hospital with Nanjing Medical University | 2003-01-01 |
| Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer (NCT00059891) | Memorial Sloan Kettering Cancer Center | 2003-01-01 |
| Patients Preference for Oral or i.v. Therapy (NCT00212589) | Odense University Hospital | 2002-12-01 |
| Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors (NCT00183833) | University of Southern California | 2002-12-01 |
| Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis (NCT00685568) | M.D. Anderson Cancer Center | 2002-11-21 |
| Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients (NCT00502502) | M.D. Anderson Cancer Center | 2002-11-01 |
| TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer (NCT00399750) | Sanofi | 2002-11-01 |
| Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer (NCT00310076) | Wake Forest University Health Sciences | 2002-10-01 |
| Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer (NCT00047762) | Genentech, Inc. | 2002-10-01 |
| Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer (NCT00055822) | The University of Texas Health Science Center at San Antonio | 2002-10-01 |
| A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study (NCT00096967) | Genentech, Inc. | 2002-10-01 |
| GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin (NCT00044343) | GlaxoSmithKline | 2002-09-01 |
| Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer (NCT00220116) | Royal Marsden NHS Foundation Trust | 2002-08-01 |
| Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer (NCT00049101) | Memorial Sloan Kettering Cancer Center | 2002-08-01 |
| Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer (NCT00066274) | UNICANCER | 2002-07-23 |
| Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer (NCT00467129) | University of Sheffield | 2002-07-01 |
| Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery (NCT00336960) | Vanderbilt-Ingram Cancer Center | 2002-07-01 |
| Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer (NCT00111761) | Amgen | 2002-07-01 |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases (NCT00268398) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2002-07-01 |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract (NCT00012246) | The University of Texas Medical Branch, Galveston | 2002-07-01 |
| Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer (NCT00173472) | National Taiwan University Hospital | 2002-07-01 |
| Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors (NCT00049608) | National Center for Complementary and Integrative Health (NCCIH) | 2002-07-01 |
| Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT00039273) | Jonsson Comprehensive Cancer Center | 2002-07-01 |
| Celecoxib in Treating Patients With Early-Stage Rectal Cancer (NCT00608595) | Vanderbilt-Ingram Cancer Center | 2002-07-01 |
| J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma (NCT00070005) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2002-06-01 |
| Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients (NCT00899626) | Vanderbilt University Medical Center | 2002-06-01 |
| Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer (NCT00075595) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2002-06-01 |
| Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00039611) | National Cancer Institute (NCI) | 2002-05-01 |
| Genetic Study of Young Patients With Colorectal Cancer (NCT00044967) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer (NCT00043004) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-05-01 |
| HAI Via Interventionally Implanted Port Catheter Systems (NCT00356161) | Charite University, Berlin, Germany | 2002-04-01 |
| Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer (NCT00202774) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2002-04-01 |
| Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy (NCT00048971) | Alliance for Clinical Trials in Oncology | 2002-04-01 |
| Do Patients With Colorectal Cancer Understand That Their Family is at Risk? (NCT00145860) | University of Chicago | 2002-04-01 |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (NCT00033605) | Alliance for Clinical Trials in Oncology | 2002-04-01 |
| Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases (NCT00119899) | Radboud University Medical Center | 2002-03-01 |
| Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma (NCT00111774) | Amgen | 2002-03-01 |
| BMS-247550 in Treating Patients With Metastatic Colorectal Cancer (NCT00033306) | University of Alabama at Birmingham | 2002-02-01 |
| Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer (NCT00126256) | Gustave Roussy, Cancer Campus, Grand Paris | 2002-02-01 |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer (NCT00039208) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-02-01 |
| CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer (NCT00033384) | University of Alabama at Birmingham | 2002-02-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT00030524) | The University of Texas Health Science Center at San Antonio | 2002-01-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer (NCT00040820) | Roswell Park Cancer Institute | 2002-01-01 |
| Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma (NCT00075556) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2002-01-01 |
| Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in Taiwan (NCT00172757) | National Taiwan University Hospital | 2002-01-01 |
| Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy (NCT00610636) | National Taiwan University Hospital | 2002-01-01 |
| Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00258232) | Barbara Ann Karmanos Cancer Institute | 2002-01-01 |
| Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis (NCT00033371) | National Cancer Institute (NCI) | 2001-12-13 |
| NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer (NCT00031616) | NewBiotics | 2001-12-01 |
| Genetic Study of Familial Factors in Patients With Colon Cancer (NCT00055848) | Alliance for Clinical Trials in Oncology | 2001-12-01 |
| Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer (NCT00027833) | Herbert Irving Comprehensive Cancer Center | 2001-12-01 |
| Curcumin for the Prevention of Colon Cancer (NCT00027495) | University of Michigan Rogel Cancer Center | 2001-12-01 |
| Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT00033748) | Alliance for Clinical Trials in Oncology | 2001-12-01 |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) (NCT00023868) | American College of Radiology Imaging Network | 2001-11-01 |
| A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women (NCT00376909) | Dartmouth-Hitchcock Medical Center | 2001-11-01 |
| ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer (NCT00026364) | National Cancer Institute (NCI) | 2001-11-01 |
| Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer (NCT00030342) | St. Luke's Medical Center | 2001-11-01 |
| Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors (NCT00028405) | Light Sciences LLC | 2001-11-01 |
| SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00028015) | NCIC Clinical Trials Group | 2001-10-30 |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer (NCT00048139) | Hoffmann-La Roche | 2001-10-01 |
| Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer (NCT00025350) | Eastern Cooperative Oncology Group | 2001-10-01 |
| Screening Tests in Detecting Colorectal Cancer (NCT00025025) | Alliance for Clinical Trials in Oncology | 2001-10-01 |
| Alternative to Two-Stage Hepatectomy (NCT00587756) | University of Milan | 2001-09-01 |
| Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer (NCT00026299) | University of Chicago | 2001-09-01 |
| BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00022477) | University of Chicago | 2001-09-01 |
| Colorectal Cancer Control in Appalachian Churches (NCT00137683) | Centers for Disease Control and Prevention | 2001-09-01 |
| Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer (NCT00028626) | Memorial Sloan Kettering Cancer Center | 2001-08-01 |
| Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer (NCT00026117) | Alliance for Clinical Trials in Oncology | 2001-08-01 |
| Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer (NCT00025142) | Stanford University | 2001-07-01 |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer (NCT00048126) | Hoffmann-La Roche | 2001-07-01 |
| Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer (NCT00023751) | Alliance for Clinical Trials in Oncology | 2001-07-01 |
| Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase (NCT01212718) | University of Ulm | 2001-07-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer (NCT00027729) | Memorial Sloan Kettering Cancer Center | 2001-06-01 |
| Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer (NCT00022698) | Hoffmann-La Roche | 2001-05-01 |
| DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer (NCT00024401) | Theradex | 2001-05-01 |
| Combination Chemotherapy in Treating Patients With Colon Cancer (NCT00046995) | Groupe Regional d'Etudes du Cancer Colorectal | 2001-05-01 |
| Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer (NCT00016198) | Prologue Research International | 2001-05-01 |
| Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver (NCT00030563) | University of Washington | 2001-05-01 |
| A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution (NCT06597903) | Norgine | 2001-05-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer (NCT00025532) | University of California, San Francisco | 2001-04-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer (NCT00010270) | University Hospital Freiburg | 2001-04-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan (NCT00016978) | National Cancer Institute (NCI) | 2001-04-01 |
| Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer (NCT00016952) | Alliance for Clinical Trials in Oncology | 2001-04-01 |
| Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer (NCT00017082) | Prologue Research International | 2001-04-01 |
| Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer (NCT00021268) | Jonsson Comprehensive Cancer Center | 2001-04-01 |
| Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery (NCT00016133) | Intracel | 2001-03-01 |
| Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver (NCT00020501) | National Institutes of Health Clinical Center (CC) | 2001-03-01 |
| Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma (NCT02118064) | Cancer Advances Inc. | 2001-03-01 |